Investments
215Portfolio Exits
47Funds
9Partners & Customers
1Service Providers
1About 5AM Ventures
5AM Ventures is a seed and early-stage venture capital firm focused on building life science companies. 5AM Ventures was founded in 2002 and is based in San Francisco, California.
5AM Ventures Headquarter Location
501 Second Street Suite 350
San Francisco, California, 94107,
United States
415-993-8570
Latest 5AM Ventures News
Jun 23, 2022
Magnetic Insight , an Alameda, Calif.-based imaging diagnostics company, raised $17m in Series B funding. The round was led by Celesta Capital, with participation from Alumni Ventures Group, Gaingels, and others, along with existing investors 5AM Ventures and Sand Hill Angels. The company intends to use the funds for the continued growth and expansion of its innovative Magnetic Particle Imaging (MPI) technology into clinical applications. Magnetic Insight’s goal is to offer clinicians a method to directly monitor cell therapy, enabling better and earlier clinical decisions, and optimal clinical outcomes. Their initial clinical application will focus on using MPI technology to monitor cell therapy (e.g., CAR-T, NK) in cancer patients. Cell therapy has fundamentally changed the cancer treatment landscape, showing impressive results in blood cancers such as leukemia and lymphoma. Unfortunately, the solid tumor landscape has proven more challenging due to an immunosuppressive tumor microenvironment that frequently excludes or inhibits cell therapy. Currently, there is no direct imaging method to monitor cell therapy localization in solid tumors to predict and monitor treatment responses. “Bringing MPI to the clinic is where we will get to see this phenomenal technology flourish and directly impact patient outcomes,” said Led by Patrick Goodwill, CEO, CTO, and Co-founder, and Steven Conolly, PhD, Co-founder of Magnetic Insight, the Cook Professor of Bioengineering, and a Professor of Electrical Engineering & Computer Sciences at UC Berkeley, Magnetic Insight has advanced magnetic particle imaging (MPI), a new diagnostic and monitoring technology platform that allows clinicians to directly monitor a cancer patient’s cell therapy location, migration, persistence, and quantity to inform clinical decision making. By directly imaging cell therapy in each patient, MPI captures cellular-level information unavailable from conventional imaging modalities, including CT, MRI, or nuclear medicine. Having started in the preclinical space by selling small animal products to leading universities worldwide, the company is now scaling up MPI technology for clinical use. The suite includes the Momentum CT MPI imager, VivoTrax and VivoTrax+ reagents, Relax MPI relaxometry software, and MagImage imaging analysis software. Multiple academic medical centers are utilizing Magnetic Insight products including Stanford Medicine, Michigan State University, University of Florida, Robarts Research Institute, Wenzhou Medical University, Karolinska Institute, University of New South Wales, Johns Hopkins University, and others. FinSMEs
5AM Ventures Investments
215 Investments
5AM Ventures has made 215 investments. Their latest investment was in Magnetic Insight as part of their Series B on June 6, 2022.
5AM Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
6/23/2022 | Series B | Magnetic Insight | $17M | No | Alumni Ventures, Celesta Capital, Gaingels, Sand Hill Angels, and Undisclosed Investors | 3 |
4/29/2022 | Series C | Portal Instruments | $7M | No | 1 | |
4/21/2022 | Series A | Dianthus Therapeutics | $100M | Yes | 2 | |
2/11/2022 | Series B | |||||
11/10/2021 | Series D |
Date | 6/23/2022 | 4/29/2022 | 4/21/2022 | 2/11/2022 | 11/10/2021 |
---|---|---|---|---|---|
Round | Series B | Series C | Series A | Series B | Series D |
Company | Magnetic Insight | Portal Instruments | Dianthus Therapeutics | ||
Amount | $17M | $7M | $100M | ||
New? | No | No | Yes | ||
Co-Investors | Alumni Ventures, Celesta Capital, Gaingels, Sand Hill Angels, and Undisclosed Investors | ||||
Sources | 3 | 1 | 2 |
5AM Ventures Portfolio Exits
47 Portfolio Exits
5AM Ventures has 47 portfolio exits. Their latest portfolio exit was CinCor Pharma on January 07, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
1/7/2022 | IPO | 4 | |||
12/6/2021 | Reverse Merger | 8 | |||
10/29/2021 | IPO | 7 | |||
Date | 1/7/2022 | 12/6/2021 | 10/29/2021 | ||
---|---|---|---|---|---|
Exit | IPO | Reverse Merger | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 4 | 8 | 7 |
5AM Ventures Acquisitions
1 Acquisition
5AM Ventures acquired 1 company. Their latest acquisition was Borean Pharma on January 15, 2008.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
1/15/2008 | Series B | $18.46M | Asset Sale | 1 |
Date | 1/15/2008 |
---|---|
Investment Stage | Series B |
Companies | |
Valuation | |
Total Funding | $18.46M |
Note | Asset Sale |
Sources | 1 |
5AM Ventures Fund History
9 Fund Histories
5AM Ventures has 9 funds, including 5AM Ventures VII.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
4/4/2022 | 5AM Ventures VII | $450M | 1 | ||
4/4/2022 | 5AM Opportunities II | ||||
2/13/2019 | 5AM Opportunities I | ||||
2/13/2019 | 5AM Ventures VI | ||||
5/27/2016 | 5AM Ventures V |
Closing Date | 4/4/2022 | 4/4/2022 | 2/13/2019 | 2/13/2019 | 5/27/2016 |
---|---|---|---|---|---|
Fund | 5AM Ventures VII | 5AM Opportunities II | 5AM Opportunities I | 5AM Ventures VI | 5AM Ventures V |
Fund Type | |||||
Status | |||||
Amount | $450M | ||||
Sources | 1 |
5AM Ventures Partners & Customers
1 Partners and customers
5AM Ventures has 1 strategic partners and customers. 5AM Ventures recently partnered with Scientist.com on June 6, 2019.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
6/2/2019 | Partner | United States | Scientist.com Partners With 5AM Ventures to Create an R&D Marketplace for Biotech Startups SAN DIEGO -- -- Scientist.com , the world 's largest marketplace for outsourced R&D services , today announced a partnership with 5AM Ventures , a leading venture capital firm focused on building next-generation life science companies . | 1 |
Date | 6/2/2019 |
---|---|
Type | Partner |
Business Partner | |
Country | United States |
News Snippet | Scientist.com Partners With 5AM Ventures to Create an R&D Marketplace for Biotech Startups SAN DIEGO -- -- Scientist.com , the world 's largest marketplace for outsourced R&D services , today announced a partnership with 5AM Ventures , a leading venture capital firm focused on building next-generation life science companies . |
Sources | 1 |
5AM Ventures Service Providers
1 Service Provider
5AM Ventures has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
---|---|---|---|
Counsel | General Counsel |
Service Provider | |
---|---|
Associated Rounds | |
Provider Type | Counsel |
Service Type | General Counsel |
Partnership data by VentureSource
5AM Ventures Team
15 Team Members
5AM Ventures has 15 team members, including current Founder, Managing Partner, Andrew J. Schwab.
Name | Work History | Title | Status |
---|---|---|---|
John D. Diekman | Founder | Current | |
Andrew J. Schwab | Bay City Capital | Founder, Managing Partner | Current |
Jeremy P. Springhorn | Syros Pharmaceuticals, Flagship Pioneering, and Alexion Pharmaceuticals | Chief Executive Officer | Current |
Stephen Bonelli | Chief Financial Officer | Current | |
Rebecca Lucia | Chief Financial Officer | Current |
Name | John D. Diekman | Andrew J. Schwab | Jeremy P. Springhorn | Stephen Bonelli | Rebecca Lucia |
---|---|---|---|---|---|
Work History | Bay City Capital | Syros Pharmaceuticals, Flagship Pioneering, and Alexion Pharmaceuticals | |||
Title | Founder | Founder, Managing Partner | Chief Executive Officer | Chief Financial Officer | Chief Financial Officer |
Status | Current | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.